Findings highlight the Pfizer ... vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in children.

Pfizer also saw sales of its COVID vaccine Comirnaty grow 9 per cent to US$1.4 billion. Pfizer also said Tuesday that it pulled in US$854 million in revenue from products tied to the drugmaker ...

Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full-year 2024 guidance (1) for both Revenues and Adjusted (2) diluted EPS. The third-quarter 2024 ...

Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

VSD also identified a signal for ischemic stroke for both mRNA vaccines, but the findings were not consistent. Previously, VSD identified a statistical signal for the Pfizer/BioNTech bivalent ...